MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Darkens on exposure to light so must be stored in airtight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Colchicine 500microgram tablets (Wockhardt UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Procoralan 5mg tablets (Servier Laboratories Ltd).

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Procoralan 7.5mg tablets (Servier Laboratories Ltd).

Stability Notes

Store in an airtight container. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Cymbalta 30mg gastro-resistant capsules (Eli Lilly and Company Ltd).

Stability Notes

Caution in handling by female operatives. Avoid handling leaking capsules. Should not be handled by pregnant women and women of childbearing potential.

Provenance

This compatibility recommendation is derived from Combodart 0.5mg/0.4mg capsules (GlaxoSmithKline UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Procoralan 5mg tablets (Servier Laboratories Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Procoralan 7.5mg tablets (Servier Laboratories Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.